Your search returned 2 results.

Results
	1.	Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells. [electronic resource] by Franke, N E Niewerth, D Assaraf, Y G van Meerloo, J Vojtekova, K van Zantwijk, C H Zweegman, S Chan, E T Kirk, C J Geerke, D P Schimmer, A D Kaspers, G J L Jansen, G Cloos, J Producer: 20120604 In: Leukemia vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease. [electronic resource] by Smits, B M Lelieveld, P H C Ververs, F A Turkenburg, M de Koning, C van Dijk, M Leavis, H L Boelens, J J Lindemans, C A Bloem, A C van de Corput, L van Montfrans, J Nierkens, S van Gijn, M E Geerke, D P Waterham, H R Koenderman, L Boes, M Producer: 20201019 In: Clinical immunology (Orlando, Fla.) vol. 212 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search